⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Bronstein, Gewirtz & Grossman, LLC Encourages Ultragenyx Pharmaceutical Inc. (RARE) Investors to Inquire about Securities Investigation
accessnewswire.com
RARE
Levi & Korsinsky Investigates Possible Securities Fraud by Ultragenyx Pharmaceutical Inc. (RARE)
accessnewswire.com
RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
accessnewswire.com
RARE
Levi & Korsinsky Launches Fraud Investigation on Behalf of Ultragenyx Pharmaceutical Inc. (RARE) Shareholders
accessnewswire.com
RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
accessnewswire.com
RARE
Protect Your Investment: Contact Levi & Korsinsky About The Ultragenyx Pharmaceutical Inc. (RARE) Investigation
accessnewswire.com
RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
accessnewswire.com
RARE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
globenewswire.com
RARE
Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
globenewswire.com
RARE
Shareholders Alert: Investigation Into Ultragenyx Pharmaceutical Inc. (RARE) - Contact Levi & Korsinsky to Protect Your Rights
accessnewswire.com
RARE